The World Bank Report No: ISR10731 Implementation Status & Results Yemen, Republic of Yemen Schistosomiasis (P113102) Public Disclosure Copy Operation Name: Yemen Schistosomiasis (P113102) Project Stage: Implementation Seq.No: 7 Status: ARCHIVED Archive Date: 05-Jun-2013 Country: Yemen, Republic of Approval FY: 2010 Product Line: IBRD/IDA Region: MIDDLE EAST AND NORTH AFRICA Lending Instrument: Specific Investment Loan Implementing Agency(ies): Key Dates Board Approval Date 17-Dec-2009 Original Closing Date 30-Jun-2016 Planned Mid Term Review Date 31-Dec-2013 Last Archived ISR Date 25-Nov-2012 Effectiveness Date 03-Aug-2010 Revised Closing Date 30-Jun-2016 Actual Mid Term Review Date Project Development Objectives Project Development Objective (from Project Appraisal Document) The project objective is to decrease the prevalence and intensity of infection of both urinary and intestinal Schistosomiasis among school-aged children by 2015 in endemic regions in Yemen. Has the Project Development Objective been changed since Board Approval of the Project? Yes No Component(s) Component Name Component Cost Preventive Chemotherapy 22.65 Independent Monitoring, Audit, and Project Administration 2.35 Overall Ratings Previous Rating Current Rating Progress towards achievement of PDO Satisfactory Satisfactory Public Disclosure Copy Overall Implementation Progress (IP) Moderately Satisfactory Satisfactory Overall Risk Rating Implementation Status Overview The preliminary coverage results of the first round of treatment for the second year campaign showed that about 8.2 million people (children and adults) have been treated, of which 4.2 million are school-aged children which represents 88% of target. A project restructuring has been completed to support a number of new areas under the project for other Neglected Tropical Diseases (NTD). A new component was added under the project to support a results-based de-worming program and control of other neglected tropical diseases in Yemen with a focus on trachoma. Page 1 of 4 The World Bank Report No: ISR10731 Locations Country First Administrative Division Location Planned Actual Yemen Not Entered Republic of Yemen Public Disclosure Copy Results Project Development Objective Indicators Indicator Name Core Unit of Measure Baseline Current End Target Prevalence of infection Percentage Value 19.40 10.00 Date 30-Jun-2012 22-May-2013 30-Jun-2016 Comments For high and meso endemic areas Urinary schistosomiasis: intensity of infection Number Value 6.87 50.00 Date 30-Jun-2012 22-May-2013 30-Jun-2016 Comments 3.6% is the prevalence of < 50 eggs/ 10 ml heavy infection Intestinal schistosomiasis: intensity of infection Number Value 14.00 100.00 Date 30-Jun-2012 22-May-2013 30-Jun-2016 Comments 4.7% for Prevalence of Heavy epg and Medium infection. Intermediate Results Indicators Indicator Name Core Unit of Measure Baseline Current End Target Geographical coverage Percentage Value 0.00 62.60 90.00 Date 22-May-2013 30-Jun-2016 Comments Treated: 139 districts Target: 222 (139 endemic plus 83 suspected endemic). Public Disclosure Copy The project has achieved its first year of implementation target. Program coverage - Targeted enrolled and Percentage Value 0.00 84.70 75.00 non-enrolled school-age children Date 22-May-2013 30-Jun-2016 Comments The project has achieved its end of project target for the first year of implementation Page 2 of 4 The World Bank Report No: ISR10731 Program coverage - Targeted enrolled school- Percentage Value 0.00 91.20 80.00 age children Date 22-May-2013 30-Jun-2016 Comments The project has achieved its Public Disclosure Copy end of project target for the first year of implementation Program coverage - Targeted non-enrolled Percentage Value 0.00 73.70 70.00 school-age children Date 22-May-2013 30-Jun-2016 Comments The project has achieved its end of project target for the first year of implementation Direct project beneficiaries Number Value 0.00 6035573.00 6000000.00 Date 22-May-2013 30-Jun-2016 Comments The project has achieved its . end of project target for the first year of implementation Female beneficiaries Percentage Value 0.00 49.30 50.00 Sub Type Supplemental Drug Availability - Timely Information to WHO Yes/No Value Yes Yes Yes Date 22-May-2013 30-Jun-2016 Comments Results after two rounds of treatment of the first year 2011 campaign Drugs Availability - At Governorate Level Yes/No Value Yes Yes Yes Date 22-May-2013 30-Jun-2016 Comments The project has achieved its end of project target for the first year of implementation Health personnel receiving training (number) Number Value 18419.00 20000.00 Public Disclosure Copy Date 22-May-2013 30-Jun-2016 Comments Data on Financial Performance (as of 05-Mar-2013) Financial Agreement(s) Key Dates Project Ln/Cr/Tf Status Approval Date Signing Date Effectiveness Date Original Closing Date Revised Closing Date P113102 IDA-H5420 Effective 17-Dec-2009 06-Jan-2010 03-Aug-2010 30-Jun-2016 30-Jun-2016 Disbursements (in Millions) Page 3 of 4 The World Bank Report No: ISR10731 Project Ln/Cr/Tf Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed P113102 IDA-H5420 Effective XDR 15.80 15.80 0.00 8.18 7.62 52.00 Public Disclosure Copy Disbursement Graph Key Decisions Regarding Implementation NA Restructuring History Level two Approved on 27-Mar-2013 Related Projects Public Disclosure Copy There are no related projects. Page 4 of 4